Skip to content

Myocardial Protection With Histidine-Tryptophan- Ketoglutarate (HTK) Solution in Comparison With Hypothermic Hyperkalemic Blood (HHB) Solution in The Correction of Acyanotic Congenital Heart Diseases.

Myocardial Protection With Histidine-Tryptophan- Ketoglutarate (HTK) Solution in Comparison With Hypothermic Hyperkalemic Blood (HHB) Solution in The Correction of Acyanotic Congenital Heart Diseases.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202109777317416
Enrollment
60
Registered
2021-09-28
Start date
2020-02-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Group HTK
Group HHB

Sponsors

Faculty of medicine at Ain Shams university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Acyanotic congenital heart diseases undergoing total repair under cardiopulmonary bypass. Aged from 6 months to 2 years of both sexes. Scheduled for elective operations.

Exclusion criteria

Exclusion criteria: Reoperation. Scheduled for palliative surgeries. Undergoing emergency surgeries. Patients with reduced left ventricular function, determined by left ventricular ejection fraction less than 40%. Patients with renal or liver impairment, determined by elevated creatinine levels or liver enzymes ‘AST and ALT’ more than normal values for age. Patients with any neurological dysfunction as epilepsy and cerebral palsy (CP).

Design outcomes

Primary

MeasureTime frame
Level of Troponins

Secondary

MeasureTime frame
The left ventricular ejection fraction (EF %).;The left ventricular fractional shortening FS.;The maximum vasoactive inotropic score VIS. The VIS was calculated according to Gaies et al study as follows: VIS= dopamine dose (mcg/kg/min) + dobutamine dose (mcg/kg/min) + 100 x epinephrine dose (mcg/kg/min) +10 x milrinone dose (mcg/kg/min) + 10,000 x vasopressin dose (U/kg/min) + 100 x norepinephrine dose (mcg/kg/min);ICU length of stay;Hospital length of stay ;Incidence of prolonged postoperative mechanical ventilation.

Countries

Egypt

Contacts

Public ContactOssama Mansour

Vice Dean of research committee at faculty of medicine

viced.research@med.asu.edu.eg+20224346344

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026